RaQualia Pharma Inc. (TYO:4579)
725.00
-18.00 (-2.42%)
Nov 18, 2026, 10:14 AM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 18.87 billion as of November 17, 2026. It is the 23,549th most valuable company in the world and the 1,956th biggest in Japan. Its market cap has increased by 42.63% in one year.
Market Cap
18.87B
Enterprise Value
16.59B
Revenue
4.02B
Global Rank
Country Rank
#1,956 Japan
PE Ratio
53.73
ChartMarket Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 18.87B, a decrease of -5.17%. That is a compound annual growth rate of -0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 18.87B | -23.60% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 30.90B |
| Japan Tissue Engineering | 26.52B |
| Innovacell | 22.58B |
| CanBas | 13.94B |
| Stella Pharma | 13.50B |
| ReproCELL | 11.64B |
| AnGes | 10.94B |
| Kubota Pharmaceutical Holdings | 8.59B |